MTX administration increased mRNA expression of receptor activator of NF-κB ligand (RANKL), osteoprotogerin (OPG), interleukin-6 (IL-6), and IL-1β in the metaphysis bone compared to control rats. (A,B) Quantitative RT-PCR of osteoclastogenesis regulators RANKL and OPG, respectively, within the metaphysis; (C) Ratio of relative mRNA expression of RANKL to OPG; (D–F) Quantitative RT-PCR of pro-inflammatory cytokines IL-6, IL-1β, and tumor necrosis factor-alpha (TNF-α), respectively. n = 6, *
p < 0.05 and **
p < 0.01 vs. control; #
p < 0.01 between Gen and MTX alone groups, and δ
p < 0.05 between Gen alone and Gen/MTX groups.